Pembrolizumab plus nab-paclitaxel active as salvage strategy in urothelial carcinoma
Given the efficacy and safety demonstrated, there may be a role going forward for the pembrolizumab/nab-paclitaxel combination in earlier disease stages.
Related Articles
Perioperative Sacituzumab Govitecan Plus Pembrolizumab Is Safe, Active in MIBC
Perioperative sacituzumab govitecan-hziy plus pembrolizumab was safe and active in muscle-invasive bladder cancer.
Perioperative Sacituzumab Govitecan Plus Pembrolizumab Is Safe, Active in MIBC
Perioperative sacituzumab govitecan-hziy plus pembrolizumab was safe and active in muscle-invasive bladder cancer.
Perioperative Sacituzumab Govitecan Plus Pembrolizumab Is Safe, Active in MIBC
Perioperative sacituzumab govitecan-hziy plus pembrolizumab was safe and active in muscle-invasive bladder cancer.
Neoadjuvant SG/Pembro, Response-Adapted Bladder Sparing in MIBC | GU Oncology Now
Drs. Necchi and Tawagi break down in detail the first results of SURE-02 in patients with muscle-invasive bladder cancer.
Post-ASCO 2025 GU Cancer Highlights Archives – VJOncology
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our…
Post-ASCO 2025 GU Cancer Highlights Archives – VJOncology
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our…